Purchase Order 75F40120P00341

Award Date 6/30/20
Potential Completion Date 12/31/20
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Pablo, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID 75N90019P00629 was issued by the National Institutes of Health (NIH) Clinical Center to Cell Line Genetics, Inc. for $11,200.00. The contract is for a firm fixed-price purchase order with a performance period ending on June 30, 2020. The contract was not set aside for any special type of business. Cell Line Genetics, Inc. is a for-profit organization that is minority-owned, woman-owned, and Hispanic American-owned. This award appears to be related to a...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...
The Centers for Disease Control and Prevention (CDC) awarded a $249,662 purchase order to Cell Microsystems Inc. to procure cell lines in support of the agency's biomedical research and public health initiatives. The firm fixed price contract has a period of performance from September 11, 2023 through October 30, 2023 for delivery of the requested cell lines to CDC facilities in Durham, North Carolina. No subcontractors or set aside designations were identified. This award advances the CDC's...
This firm-fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Lifeline Cell Technology, LLC, a small business manufacturer of goods. The $15,100.80 contract is for the provision of pulmonary epithelial cultures. The contract was set aside for small businesses and has a completion date of September 28, 2018. Lifeline Cell Technology, LLC...
The National Institutes of Health awarded a $249,942 firm fixed price purchase order to Wicell Research Institute, Inc. to obtain 128 specific human pluripotent stem cell lines in support of the Helping to End Addiction Long-term Initiative. The award was made non-competitively based on Wicell being the only source capable of providing the cell lines due to scientific continuity needs. Prior to shipment, each cell line must undergo testing to verify identity, sterility, and normal karyotype....
This federal contract award was issued by the Food and Drug Administration (FDA) to the American Type Culture Collection (ATCC), a nonprofit biological resource center, for the cryopreservation and storage of two cell lines infected with a retrovirus. The contract, valued at $73,529.00, is a firm-fixed price purchase order with an ultimate completion date of August 22, 2025. The original solicitation, which was issued as full and open competition, requested the expansion, vial preparation, and...
The National Institute on Aging (NIA) awarded a 5-year, $10,513,138 definitive contract to the Coriell Institute for Medical Research, Inc. to continue operating an aging cell repository that provides well-characterized cell lines and DNA to researchers studying the biology of aging. The contract supports maintaining existing cell stocks, establishing new cell lines, isolating DNA, and distributing materials to investigators. There is no set-aside designation for this award. Coriell Institute,...
This is a firm-fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bioreliance Corporation, a foreign-owned, for-profit organization, for the storage of Vero and MDCK cells in liquid nitrogen under compliant Good Manufacturing Practice (cGMP) and compliant Good Laboratory Practice (cGLP) conditions. The contract has a ceiling value of $131,226.00 and a period of performance ending on May 31, 2026. The contract was awarded on a sole-source basis, as the...
Synthego Corporation will deliver customized human cell lines to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under a $22,650 firm fixed price purchase order. Specifically, Synthego will supply vials of immortalized THP-1 cells containing a single nucleotide variant or codon change in the protein coding sequence of an unspecified chromosome. The estimated turnaround time is 17 weeks for this small cell clone order placed under NIAMS' research support...
This federal contract award to the American Type Culture Collection (ATCC), a nonprofit biological resource center, is to procure an additional 75 cell lines and/or derivatives selected by the Office of Cancer Genomics (OCG) to be sent to Battelle Pacific Northwest National Laboratory. The $92,305.00 firm fixed-price Delivery Order is awarded under the Molecular Epidemiology Assay Support (MEAS) major program by the National Cancer Institute, which is part of the Department of Health and Human...

CELL LINE IMMORTALIZATION

Posted 6/30/20, 12:00 AM